NCT05754892View on ClinicalTrials.gov

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

June 30, 2030

Conditions
CancerAdrenal
Interventions
OTHER

Blood sample

For patients with ACC : blood (30ml) sampling before surgery and every 3 months during 3 years after surgery for biobanking For patients with MPP : blood (30ml) sampling before surgery and every 6 to 12 months for MPP during 3 years after surgery for biobanking

OTHER

Urine sample

For patients with ACC : urine sampling before surgery and every 3 months during 3 years after surgery for biobanking For patients with MPP : urine sampling before surgery and every 6 to 12 months for MPP during 3 years after surgery for biobanking

OTHER

Tumor sample

For patients with ACC and patients with MPP : tumor sample during surgery

Trial Locations (1)

75014

RECRUITING

GH Paris Centre, Assistance Publique - Hôpitaux de Paris, Paris

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER